Use of Rho kinase Inhibitors in Ophthalmology: A Review of the Literature

The use of Rho Kinase (ROCK) inhibitors as therapeutic agents in ophthalmology has been a topic of discussion for several years, particularly in the realm of glaucoma, Fuchs’ endothelial dystrophy, and diabetic retinopathy. In this review, the authors provide a detailed and comprehensive overview of...

Descripción completa

Detalles Bibliográficos
Autores principales: Moshirfar, Majid, Parker, Lawsen, Birdsong, Orry C., Ronquillo, Yasmyne C., Hofstedt, Daniel, Shah, Tirth J., Gomez, Aaron T., Hoopes, Phillip C Sr.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medical Hypothesis, Discovery & Innovation Ophthalmology 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205677/
https://www.ncbi.nlm.nih.gov/pubmed/30386798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205677/
https://www.ncbi.nlm.nih.gov/pubmed/30386798

Ejemplares similares